Labang, Yna Elidha N.

HRN: 17-91-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2025
CEFUROXIME 750MG (VIAL)
07/22/2025
07/29/2025
IV
565
Q8H
PCAP C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: